| Tag | Content |
|---|
EnhancerAtlas ID | HS012-15730 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr19:50926300-50926860 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESR1 | MA0112.3 | chr19:50926838-50926855 | CAGGTGACCCTGACCTT | - | 6.23 | | ESR2 | MA0258.2 | chr19:50926839-50926854 | AGGTGACCCTGACCT | + | 6.12 | | ZNF263 | MA0528.1 | chr19:50926798-50926819 | AGAGGAGGAAGTGGAGGGAGA | + | 8 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_11229 | chr19:50916608-50928040 | CD20 | | SE_59003 | chr19:50917352-50937115 | Ly3 | | SE_60926 | chr19:50917454-50936457 | DHL6 | | SE_61162 | chr19:50916986-50937108 | HBL1 | | SE_61906 | chr19:50917027-50939735 | Toledo | | SE_63107 | chr19:50917418-50936805 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I050421 | chr19 | 50925156 | 50926343 |
|
Enhancer Sequence | GGTAAGGGGA CAGTTAAAAT CAAGCCCAAA CCAGGTGTGG TGGTGCACGC CTGTAATCCC 60
AGCTGCTTGA GAGGCTGAGG TGGGAGGAGG ATTGCTTGAG CCCAGAAGGT CGAGGCAATC 120
CACTGCACTC CAGTCTGGGC AACAGAGCAA GACCCTGTCT CAAAAAAAAA AAAAAAAAAG 180
AAAAAGAAAA GAAAACTCAA GCTCAGTCAT TTGGTTGAGG TTTGCTGGGT GCCGGGCACT 240
GCATTGAGAC TGCACATAGT AAGCCCTGCA GCGGCCTCCC AGGTTACGTT CCGTTGTTGC 300
CCCTCTGAAC AAGTGAGTCA AGAGAGGTAG TGACAGGAAG CCAGGGACAG GGCAGACTCG 360
CATTACCTGT GTTGGGCCGG CTTTGAGGAG GTACCTCAGG TGTCCCCTGG CCACAGCGTG 420
GTGATCTGAA CAAAGGCCAA AATCTAGGCT GTCAACAAAG AGGGAGACCA GAGCCAGGAG 480
GGCCACCGCC TTGGCCTGAG AGGAGGAAGT GGAGGGAGAC AAGGGGTCCC TGGACATGCA 540
GGTGACCCTG ACCTTCCGCA 560
|
